Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,7 USD | -3,27% | -2,48% | +63,20% |
09/04 | MACROGENICS, INC. : TD Cowen is positief over | ZM |
04/04 | Sectorupdate: Aandelen in de gezondheidszorg gemengd in de middaghandel | MT |
Vakgebied
Aantal werknemers: 339
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Collaborative and Other Agreements
49,3
%
| 119 | 78,5 % | 29 | 49,3 % | -75,70% |
Monoclonal Antibody-based Therapeutics
30,5
%
| 17 | 11,0 % | 18 | 30,5 % | +7,25% |
Contract Manufacturing
16,7
%
| 14 | 9,2 % | 10 | 16,7 % | -29,70% |
Government Agreements
2,6
%
| 2 | 1,3 % | 2 | 2,6 % | -19,08% |
Royalty
0,7
%
| - | - | 0 | 0,7 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 152 | 100,0 % | 59 | 100,0 % | -61,33% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Koenig
FOU | Founder | 71 | 14-08-00 |
James Karrels
DFI | Director of Finance/CFO | 57 | 01-05-08 |
Stephen Eck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-07-20 |
Eric Risser
COO | Chief Operating Officer | 51 | 01-03-09 |
Ezio Bonvini
CTO | Chief Tech/Sci/R&D Officer | 70 | 01-06-03 |
Jeffrey Peters
LAW | General Counsel | 53 | 01-08-15 |
Corporate Officer/Principal | 57 | 01-01-13 | |
Lynn Cilinski
AUD | Comptroller/Controller/Auditor | 66 | 01-10-03 |
Syd Johnson
PRN | Corporate Officer/Principal | - | 01-01-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Margaret Liu
BRD | Director/Board Member | 66 | 03-01-23 |
David Stump
BRD | Director/Board Member | 74 | 19-09-13 |
Edward Hurwitz
BRD | Director/Board Member | 60 | 01-10-04 |
William Heiden
CHM | Chairman | 64 | 22-05-22 |
Scott Jackson
BRD | Director/Board Member | 60 | 25-01-17 |
Scott Koenig
FOU | Founder | 71 | 14-08-00 |
Federica O’Brien
BRD | Director/Board Member | 66 | 10-02-21 |
Director/Board Member | 51 | 03-01-23 | |
Karen Ferrante
BRD | Director/Board Member | 66 | 25-01-17 |
Jay Siegel
BRD | Director/Board Member | 71 | 13-11-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 62 560 502 | 60 313 787 ( 96,41 %) | 0 | 96,41 % |
Bedrijfsgegevens
MacroGenics, Inc.
9704 Medical Center Drive
20850-3368, Rockville
+301 251 5172
http://www.macrogenics.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+63,20% | 982 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,46% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-10,16% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |
- Beurs
- Aandelen
- Koers MGNX
- Onderneming MacroGenics, Inc.